[go: up one dir, main page]

FR2419725A1 - Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales - Google Patents

Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales

Info

Publication number
FR2419725A1
FR2419725A1 FR7807155A FR7807155A FR2419725A1 FR 2419725 A1 FR2419725 A1 FR 2419725A1 FR 7807155 A FR7807155 A FR 7807155A FR 7807155 A FR7807155 A FR 7807155A FR 2419725 A1 FR2419725 A1 FR 2419725A1
Authority
FR
France
Prior art keywords
compsns
alstonine
serpentine
sempervirine
antitumoural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7807155A
Other languages
English (en)
Other versions
FR2419725B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7807155A priority Critical patent/FR2419725A1/fr
Priority to FR7830663A priority patent/FR2439783A1/fr
Priority to FR7905853A priority patent/FR2450607A2/fr
Publication of FR2419725A1 publication Critical patent/FR2419725A1/fr
Application granted granted Critical
Publication of FR2419725B1 publication Critical patent/FR2419725B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D459/00—Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation comme médicaments, utiles notamment pour le traitement des cancers et tumeurs, d'alcaloïdes appartenant au groupe des beta -carbolines quaternaires, tels que la serpentine, l'alstonine et la sempervirine. L'invention concerne également un procédé de préparation de serpentine et d'alstonine l'état pur.
FR7807155A 1978-03-13 1978-03-13 Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales Granted FR2419725A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR7807155A FR2419725A1 (fr) 1978-03-13 1978-03-13 Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales
FR7830663A FR2439783A1 (fr) 1978-03-13 1978-10-27 Procede d'extraction de la serpentine et de l'alstonine
FR7905853A FR2450607A2 (fr) 1978-03-13 1979-03-07 Composition pharmaceutique contenant comme principe actif la flavopereine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7807155A FR2419725A1 (fr) 1978-03-13 1978-03-13 Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales

Publications (2)

Publication Number Publication Date
FR2419725A1 true FR2419725A1 (fr) 1979-10-12
FR2419725B1 FR2419725B1 (fr) 1981-10-23

Family

ID=9205684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7807155A Granted FR2419725A1 (fr) 1978-03-13 1978-03-13 Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales

Country Status (1)

Country Link
FR (1) FR2419725A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
WO1994002829A1 (fr) * 1992-07-28 1994-02-03 Abraxas Bio Labs Sa Methode de cytodiagnostic utilisant l'alstonine comme marqueur selectif et kit de diagnostic contenant ce marqueur
WO2002094270A3 (fr) * 2001-05-18 2003-04-03 Chemokine Therapeutics Corp Medicaments a base de ligands de recepteurs mip-1 alpha destines aux maladies auto-immunes et a mediation par cellules t
US11083714B2 (en) 2018-03-31 2021-08-10 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1702M (fr) * 1961-12-06 1963-02-18 Smith Brothers Composition pharmaceutique active contre la toux.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1702M (fr) * 1961-12-06 1963-02-18 Smith Brothers Composition pharmaceutique active contre la toux.

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CA1947 *
CA1959 *
CA1968 *
CA1969 *
CA1970 *
CA1974 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
WO1994002829A1 (fr) * 1992-07-28 1994-02-03 Abraxas Bio Labs Sa Methode de cytodiagnostic utilisant l'alstonine comme marqueur selectif et kit de diagnostic contenant ce marqueur
FR2694193A1 (fr) * 1992-07-28 1994-02-04 Abraxas Bio Labs Sa Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
US5567593A (en) * 1992-07-28 1996-10-22 Beljanski; Mirko Cytodiagnostic method using alstonine as a selective marker, and diagnostic kit containing marker
WO2002094270A3 (fr) * 2001-05-18 2003-04-03 Chemokine Therapeutics Corp Medicaments a base de ligands de recepteurs mip-1 alpha destines aux maladies auto-immunes et a mediation par cellules t
US11083714B2 (en) 2018-03-31 2021-08-10 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Also Published As

Publication number Publication date
FR2419725B1 (fr) 1981-10-23

Similar Documents

Publication Publication Date Title
AU498484B2 (en) Irradiated laminates
GB1558370A (en) Blood treating apparatus
AU1948676A (en) Water-dispersible polyurethane
JPS5212049A (en) Recording and reproducing unit for games
GB1541278A (en) Comounication system particularly suitable for establishing radioelectric communication in tunnels and along linear paths above the ground
YU39173B (en) Machine for fullering tracks, particularly machine for fullering and levelling tracks
FR2419725A1 (fr) Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales
AU504126B2 (en) Abrasive throwing machine for treating horizontal or inclined surfaces
AU501291B2 (en) Games apparatus
GB1553256A (en) Coinoperated locker
GB1553255A (en) Coinoperated locker
NL175915C (nl) Werkwijze voor het bereiden van coronair werkzame preparaten, alsmede werkwijze voor het bereiden van een in dergelijke preparaten toe te passen 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrofenyl) -1,4-dihydropyridine-5-carbonzure-ester.
JPS525843A (en) Organic spray preparations
AU514194B2 (en) Treating trees
JPS51129451A (en) Organic abrasive
AU501183B2 (en) Floor treating machines
FR2322756A1 (fr) Roulette pour meuble, notamment roulette orientable.
GB1557044A (en) Nitrogen oxide catalysis
EP0139005A4 (fr) Composition antitumorale, procede de traitement des tumeurs et utilisation de la composition pour le traitement des tumeurs.
CS189163B1 (en) Facility for cutting,concentration and lapping the wood
JPS527160A (en) Supersonic treatment process
AU500932B2 (en) Grinding milland method
Morozumi et al. Effect of C on the Anneal Hardening of Irradiated V
CA1006481A (en) Carrier for hockey sticks, skis and the like
CS182540B1 (en) Apparatus for controlling bearing play in hermetic pumps,especially for nuclear plants

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
TP Transmission of property
SN Distraint notified (in the national patent register)
JU Final juridical decision affecting the ownership or exploitation of an industrial property right
ML Cancellation of distraint
TP Transmission of property